HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oksana Palyha Selected Research

Oksana Palyha Research Topics

Disease

9Obesity
05/2012 - 02/2010
3Body Weight (Weight, Body)
12/2011 - 04/2010
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 11/2015
1Insulin Resistance
01/2019
1Hyperglycemia
11/2015
1Cardiovascular Diseases (Cardiovascular Disease)
05/2012
1Weight Loss (Weight Reduction)
02/2011

Drug/Important Bio-Agent (IBA)

6bombesin receptor subtype 3IBA
05/2012 - 02/2010
4Bombesin Receptors (Bombesin Receptor)IBA
03/2012 - 04/2010
21,1,1- trifluoro- 2- (4- (1H- pyrazol- 1- yl)phenyl)- 3- (4- ((1- (trifluoromethyl)cyclopropyl)methyl)- 1H- imidazol- 2- yl)propan- 2- olIBA
02/2011 - 01/2011
1Insulin (Novolin)FDA Link
01/2019
1N- ((4- (1- (3- (3,5- dichlorophenyl)- 5- (6- methoxynaphthalen- 2- yl)- 1H- pyrazol- 1- yl)ethyl)phenyl)carbonyl)- beta- alanineIBA
11/2015
1Glucagon (Glukagon)FDA Link
11/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
05/2012
1ResistinIBA
05/2012
1AdipokinesIBA
05/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2012
1Carboxylic AcidsIBA
05/2010

Therapy/Procedure

1Oral Administration
04/2010